SHANGHAI – Two Chinese biopharmaceutical firms have been added to an ongoing corruption probe in China that has already expanded to cover several multinationals. They include Chia Tai Tianqing Pharmaceutical Group, which is majority owned by Sino Biopharmaceutical Ltd., and privately held Gan & Lee Biotechnology Co. Ltd.